CN101195009B - Powder medicament for treating scrotum eczema - Google Patents

Powder medicament for treating scrotum eczema Download PDF

Info

Publication number
CN101195009B
CN101195009B CN2007103010594A CN200710301059A CN101195009B CN 101195009 B CN101195009 B CN 101195009B CN 2007103010594 A CN2007103010594 A CN 2007103010594A CN 200710301059 A CN200710301059 A CN 200710301059A CN 101195009 B CN101195009 B CN 101195009B
Authority
CN
China
Prior art keywords
eczema
medicine
treatment
eczema scrotum
powder medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007103010594A
Other languages
Chinese (zh)
Other versions
CN101195009A (en
Inventor
徐生富
华水土
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2007103010594A priority Critical patent/CN101195009B/en
Publication of CN101195009A publication Critical patent/CN101195009A/en
Application granted granted Critical
Publication of CN101195009B publication Critical patent/CN101195009B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine preparation, namely a powder medicament for curing scrotal eczema. The medicament is constituted by raw materials with following weights: god terror stone 50g, lime 50g, talc 50g, coptis chinensis 30g, radix stemonaestemona root 30g, dried alum 30g, polygonum cuspidate 20g and phellodendron 20g. The invention has the advantages of novel dispense prescriptions, low cost, easy and convenient manufacture, convenient use and prominent effect.

Description

A kind of powder agent medicine for the treatment of eczema scrotum
Technical field:
The present invention relates to a kind of Chinese medicine preparation, promptly treat the very good a kind of powder agent medicine for the treatment of eczema scrotum of eczema scrotum effect.
Background technology:
Eczema scrotum is a kind of anaphylactoid dermatosis that is caused by multiple internal and external factor, and its symptom shows as: erythema, pimple, vesicle, abscess, very itch etc.At present, the medicine for the treatment of eczema scrotum both at home and abroad is more, but has shortcomings such as price height, medical expense is big, effect is also unsatisfactory.
Summary of the invention:
The objective of the invention is at the present weak point on treatment eczema scrotum, and the powder agent medicine and the preparation method of a kind of new raw material of Chinese medicine combination, treatment eczema scrotum evident in efficacy are provided.
Technical scheme of the present invention is achieved in that
A kind of powder agent medicine for the treatment of eczema scrotum, its medicine are to be made by the raw material of following weight: Sulfur, Calx, each 50 gram of Talcum, Rhizoma Coptidis, the Radix Stemonae, each 30 gram of dried Alumen, Rhizoma Polygoni Cuspidati, each 20 gram of Cortex Phellodendri.
A kind of powder agent medicine for the treatment of eczema scrotum, the preparation method of its medicine is: above-mentioned raw material of Chinese medicine is dried, be ground into thin medicated powder, cross 120 mesh sieves, it is standby to bottle, powder agent medicine.
A kind of powder agent medicine for the treatment of eczema scrotum, its Therapeutic Principle is a clearing away heat and eliminating dampness, the parasite killing detoxifcation.On composition of raw materials, follow the property of medicine through belonging to, lay particular stress on clearing away heat and eliminating dampness, take into account whole machine balancing, the parasite killing of stopping over detoxifcation.Sulfur has tonifying YANG, insecticidal action in the medicine, Calx has dampness, parasite killing, analgesic therapy, anastalsis, Talcum has heat clearing away eliminating dampness by diuresis effect, Rhizoma Coptidis, Cortex Phellodendri have heat-clearing and toxic substances removing, the effect of pathogenic fire purging dampness, the Radix Stemonae has inducing diuresis to remove edema, Detoxication, dried Alumen has dampness, Detoxication, and Rhizoma Polygoni Cuspidati has expelling wind and removing dampness, dissipating blood stasis to promote menstruationg effect.Above-mentioned Chinese medicine is through dialectical compatibility, complements each other using, and medicine is directly invested focus, thereby given play to clearing away heat and eliminating dampness effectively, and parasite killing antidotal effect is to reach the purpose of curing eczema scrotum.
The present invention has following characteristics: prescription is new, cost is low, preparation is easy, easy to use, evident in efficacy.
Using method:
Every day 3-4 time, each consumption is decided on the wound surface size.Method: dip in medicated powder with absorbent liquor ball and be coated with to pounce on and spread the affected part, get final product.
The taboo item:
1, fried sticky, the cold solid food hard, nondigestible and excitatory of taboo edible oil during the medication.
2, forbid taking orally.
Clinical therapeutic efficacy:
Criterion of therapeutical effect: a kind of curative effect for the treatment of the powder agent medicine treatment eczema scrotum of eczema scrotum judges whether mainly be dependent on the eczema scrotum symptom disappears.Medication 8 days was 1 course of treatment.Concrete curative effect is divided following three grades: cure---and the eczema scrotum symptom all disappears; Taking a turn for the better---the eczema scrotum symptom obviously alleviates; Invalid---after medication 1 course of treatment, the eczema scrotum symptom has no to disappear.
Effect: with Drug therapy eczema scrotum patient 29 examples of the present invention, treat 1 course of treatment, wherein cure 24 examples, 5 examples that take a turn for the better, cure rate is 83%, effective percentage is 100%.
Model case:
The Wang, man, 31 years old.In JIUYUE, 2006 is gone to a doctor.Patient's readme is violated eczema scrotum disease for many years, because of too embarrassed to say, oneself go to the pharmacy to buy multiple antibiosis anti-inflammatory drug and takes DeGrain.Recently this onset is serious, and pimple is very itched.Examine and see that whole scrotum is covered with pimple, many places have been scratched sepage.Adopt powder agent medicine of the present invention, logotype 8 days, eczema disappears.Visit after 6 months, do not see recurrence.

Claims (1)

1. a powder agent medicine for the treatment of eczema scrotum is characterized in that this medicine is to be made by the raw material of following weight: Sulfur, Calx, each 50 gram of Talcum, Rhizoma Coptidis, the Radix Stemonae, each 30 gram of dried Alumen, Rhizoma Polygoni Cuspidati, each 20 gram of Cortex Phellodendri.
CN2007103010594A 2007-12-11 2007-12-11 Powder medicament for treating scrotum eczema Expired - Fee Related CN101195009B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007103010594A CN101195009B (en) 2007-12-11 2007-12-11 Powder medicament for treating scrotum eczema

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007103010594A CN101195009B (en) 2007-12-11 2007-12-11 Powder medicament for treating scrotum eczema

Publications (2)

Publication Number Publication Date
CN101195009A CN101195009A (en) 2008-06-11
CN101195009B true CN101195009B (en) 2011-10-12

Family

ID=39545755

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007103010594A Expired - Fee Related CN101195009B (en) 2007-12-11 2007-12-11 Powder medicament for treating scrotum eczema

Country Status (1)

Country Link
CN (1) CN101195009B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102755548A (en) * 2012-06-28 2012-10-31 倪位文 Powder medicine for curing acute eczema scroti

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895430A (en) * 2006-06-10 2007-01-17 江国潮 Fumigant medicine for treating acute scrotal eczema and its preparation
CN1895446A (en) * 2006-05-31 2007-01-17 胡红芳 Fumigant medicine for treating chronic scrotum eczema and its preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895446A (en) * 2006-05-31 2007-01-17 胡红芳 Fumigant medicine for treating chronic scrotum eczema and its preparation
CN1895430A (en) * 2006-06-10 2007-01-17 江国潮 Fumigant medicine for treating acute scrotal eczema and its preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
周丹.阴囊湿疹的中医治疗近况.《甘肃中医》.1992,第5卷(第2期),47-48. *

Also Published As

Publication number Publication date
CN101195009A (en) 2008-06-11

Similar Documents

Publication Publication Date Title
CN101195009B (en) Powder medicament for treating scrotum eczema
CN101194988A (en) Powder medicament for treating mouth ulcer
CN101194987B (en) Powder medicament for treating recurrent mouth ulcer
CN101185704B (en) Powder agent medicine for treating aphtha
CN101185708B (en) Powder agent medicine for treating acute otitis media suppurative
CN101199626B (en) Powders medicament for treating anal eczema
CN101199688B (en) Tincture dose medicament for treating part frozen
CN101194950B (en) Powder medicine medicament for treating children's stomatitis
CN101190284A (en) Externally-cleaning medicine for treating acute scrotal eczema
CN101199650B (en) Tincture dose medicament for treating scapulohumeral periarthritis
CN101185691B (en) Powder agent medicine for treating infantile aphtha
CN101185697B (en) Ointment medicine for treating anal fissure
CN101185666B (en) Collunarium medicine for treating acute rhinitis
CN101313930A (en) Plaster medicament for treating erosion type tinea manus and pedis
CN101199695B (en) Powders medicament for treating sinusitis
CN101194977A (en) Plaster medicament for treating closed traumatic injury
CN101195010B (en) Powder medicament for treating acute soft tissue injury
CN101204441A (en) External medicine for herpes zoster
CN101194981B (en) Powder medicament for treating otitis media chronica
CN101185731B (en) Externally-applied medicine for treating chronic eczema
CN101194973B (en) Infusion medicament for treating impetigo
CN101185743A (en) Ointment shape medicament for treating soft tissue contusion
CN101194928B (en) Fumigation medicament for treating scabies
CN101194975B (en) Powder medicament for treating impetigo
CN101185680A (en) Collunarium medicine for treating chronic rhinitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111012

Termination date: 20111211